Tricyclic compound and pharmaceutical use thereof
US8552037B2 · kind B2 · utility
2Cited by
14References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 23, 2012 |
| Grant date | Oct 8, 2013 |
| Priority date | — |
| Expiry date | Oct 23, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a compound represented by the formulawhich is useful as an agent for the prophylaxis or treatment of diseases related to the action of melatonin, or a salt thereof and the like.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.